Lind Kevin Robert bought AVTX
October 1, 2025 · Form 4 insider transaction
Lind Kevin Robert bought 40,200 shares of Avalo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
40,200
Price
$0.00
Total value
N/A
InsiderLind Kevin Robert
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 2, 2025
Shares owned after40,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in three substantially equal installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.